Table 3.
Association between baseline magnesium (Mg) intake and incident fracture.
| Men | Women | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Mg intake | Cases | Subjects | Incidence rate |
HR* (95%CI) p-value |
Cases | Subjects | Incidence rate |
HR (95%CI) p-value |
| Q1 | 42 | 316 | 27 (18–36) | 1 [ref.] | 78 | 414 | 31 (23–39) | 1 [ref.] |
| Q2 | 26 | 314 | 13 (9–18) | 0.53 (0.31–0.90) P=0.02 | 73 | 411 | 30 (22–38) | 0.77 (0.52–1.14) P=0.20 |
| Q3 | 34 | 316 | 18 (10–25) | 0.56 (0.33–0.97) P=0.04 | 74 | 421 | 28 (20–36) | 0.62 (0.39–0.99) 0.05 |
| Q4 | 44 | 315 | 22 (15–29) | 0.65 (0.36–1.17) P=0.15 | 76 | 414 | 36 (25–47) | 0.56 (0.32–0.98) P=0.04 |
| Q5 | 52 | 316 | 20 (13–27) | 0.47 (0.21–1.00) P=0.05 | 61 | 411 | 27 (20–34) | 0.38 (0.17–0.82) P=0.01 |
Data are presented as hazard ratios (HRs) with correspondent 95% confidence intervals (CI).
Fully adjusted hazard ratios included as covariates: age (as continuous); total energy intake (in Kcal, as continuous); race (white vs. others); body mass index (as continuous); education (college vs. others); smoking habits (current vs. previous/never); yearly income (≥ vs. <50,000 $); Charlson co-morbidity index; use of drugs affecting positively bone (bisphosphonates, hormones, teriparatide); calcium intake (mg/day); potassium (mg/day); vitamin D intake (mg/day); alcohol intake (% of total energy intake); physical activity scale for the elderly (as continuous).